JCJoana J. Costa

Joana J. Costa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Joana J. Costa has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nature-Inspired Trojan Materials as Invisible Enablers of Advanced Humidity Sensors

    by Daniela S. Oliveira, Elizabeth S. Vieira, Gabriela V. Martins, Joana J. Costa, Rafaela M. Meira, Carlos A. Ramos, Daniela Campanhã, Gina Vilão, Joaquim Alves, P. Filipe Santos, et al.

    Nature offers a robust conceptual framework for designing next-generation adaptive, multifunctional sensing systems. Also, in sensing systems, Trojan materials add a functional dimension to the microstructure, enabling the development of high-performance humidity sensors without interfering with their macrostructure. Thus, based on a brief overview of how inspiration from plants, animals, and membranes can be used to engineer high-performance platforms for environmental humidity monitoring, combined with the functional dimension of Trojan materials, this review presents a critical framework detailing the key developments in the main categories of self-sensing materials within the scope of humidity sensors. The review addresses electronically and ionically conductive polymers, polymer composites with dispersed active fillers, and hydrogel-based or other water-compatible systems. Additionally, commercially available sensors are described, and the main challenges and future directions are identified.

  • Open Access

    Integration and Challenges of Lignocellulosic Materials into Bio-Based Construction Systems

    by Elizabeth S. Vieira, Thalita Damaceno, Joana J. Costa, António G. Abreu, Margarida Calmeiro, Sofia Gouveia, P. Filipe Santos, José Junqueira, Sandra Leitão, Nuno Simões, et al.

    The construction sector is responsible for substantial energy consumption, greenhouse gas emissions, and resource depletion, driving the search for sustainable alternatives to conventional petroleum-based insulation materials. Lignocellulosic biomass, comprising cellulose, hemicellulose, and lignin, offers a renewable resource for the development of bio-based foams with potential application in construction systems. This review provides a comprehensive analysis of bio-based foams tailored to building applications, positioning recent scientific advances against the technical properties of commercial synthetic insulation foams. Key performance parameters, including density, thermal conductivity, compressive strength, dimensional stability, water vapour diffusion resistance, and fire behaviour, are critically examined. Developments in lignocellulosic-based foams are discussed, highlighting processing strategies such as crosslinking, chemical modification, and hybrid reinforcement to enhance mechanical, thermal, and fire performance. The reported results demonstrate that lignin-based polyurethane and phenolic foams can achieve competitive compressive strength and thermal insulation, while cellulose-based aerogels and foams exhibit ultra-low density and promising conductivity values. However, challenges related to moisture sensitivity, fire classification, process scalability, standardisation, and market integration remain significant. Overall, lignocellulosic foams represent a promising pathway toward decarbonised, circular construction systems, provided that technical optimisation and regulatory alignment are successfully achieved.


  • Open Access

    Innovations in Tannin-Based Phenolic Foams: A Review of the Research

    by António G. Abreu, Joana J. Costa, P. Filipe Santos, Abel J. Duarte, Elizabeth S. Vieira, Felismina T. C. Moreira

    Research on tannin-based foams has shown promising results. However, all developments in this field have not been addressed from different perspectives, in a systematic way, and with an emphasis on sustainability. This work discusses different formulations, emphasizing their bio-based components and how modifications influence key properties. It examines life cycle assessment (LCA) studies through a sustainability lens and identifies major commercial phenolic products to highlight the practical use of tannin foams for thermal insulation. The type of tannins, as well as their sources, influences the key properties of these foams. The replacement of formaldehyde, a crosslinking agent known for its health risks, is possible, particularly through more sustainable alternatives that allow for foams with better properties than those obtained with formaldehyde. Substitution of diethyl ether with less hazardous alternatives results in foams with improved thermal and mechanical performance. The elimination of the blowing agent—the green alternative—also leads to foams with good performance. The presence of additives (surfactants, plasticizers, and fillers), some of which are sustainable, improves the mechanical properties of the foams. The performance in fire-related applications, already promising, is also enhanced by the presence of additives. An increase in understanding, combined with the sustainable nature of the various alternatives, makes tannin-based foams promising candidates for next-generation insulation and structural materials in construction.


  • Open Access

    Anti-IL-6 Receptor Treatment in Giant Cell Arteritis Patients Reduces Levels of IL-1β-Receptor Antagonist but Not IL-1β

    by Joana J. da Costa, Lisa Christ, Peter M. Villiger, Monique Vogel, Martin F. Bachmann

    This work aimed to investigate a potential link between serum IL-1β levels in patients with giant cell arteritis (GCA) and their responsiveness to combined anti-IL-6 receptor (IL-6R) and glucocorticoid (GC) treatments within the context of two separate clinical trials. IL-1β levels were analyzed in serum samples of two prospective clinical trials investigating tocilizumab in GCA patients using quantitative Polymerase Chain Reaction (qPCR) based Proximity Ligation Assays (PLA). In the phase II randomized controlled trial, serum samples from five patients were quantified at two critical time points: the commencement of the trial (Week 2) and the conclusion of the trial (Week 52). In the GUSTO trial, serum samples from nine patients were similarly analyzed using PLA at Day 0 and Week 52. Furthermore, for the GUSTO trial, serum samples from 18 patients were assessed for IL-1β and IL-1RN at six time points: days 0, 3, and 10, weeks 4, 24, and 52 by a second assay (Proximity Extension Assay, PEA). PLA results from both studies indicated that IL-1β levels were below 1 pg/mL in most of the patients, resulting in notable signal deviations within the same samples. In the analysis of the GUSTO trial, both PLA and PEA exhibited similar trends in IL-1β variations among patients from day 0 to week 52. Notably, the PEA analysis did not show significant variation over time. Furthermore, we did not find a correlation of IL-1β levels with active disease as compared to remission, but interestingly, the measurement of IL-1β receptor antagonist (IL-1RN) revealed a substantial decrease over time. Our study shows that IL-1RN but not IL-1β concentration in serum samples could be directly related to anti-IL-6R treatment in patients diagnosed with GCA.